A crucial role for the CXCL9/10/11-CXCR3 chemokine axis in anti-tumor immunity has been demonstrated in various tumors [61,62], and high levels of CXCL9/10 are associated with increased infiltration of immune cells and better prognosis in melanoma patients [63]. The gene discussed is CXCL9; the disease is neoplasm.